Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian Market

About this update from Delivra Health Brands Inc

Delivra Health Brands Launches LivRelief (TM) Itch Relief Cream in the Canadian MarketVancouver, British Columbia--(Newsfile Corp. - July 2, 2026) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that its LivReliefTM brand is launching its new Itch Relief Cream in the Canadian market. The LivRelief TM Itch Relief Cream is available to Company distributors, retailers and e-commerce channels effective immediately.This product addresses the consumer need for effective relief from itchiness associated with eczema, psoriasis and dermatitis. It can also be used for the temporary relief of minor skin irritations associated with rashes, itching, and redness due to insect bites, poison ivy, poison oak, and poison sumac. This product is formulated to support sensitive skin - it is hypoallergenic, fragrance-free, and free from parabens, petroleum, and sodium lauryl sulfate (SLS). It combines hydrocortisone, calendula and chamomile to reduce itch, irritation and inflammation.According to the Canadian Dermatology Association[1], up to 17% of Canadians will suffer from atopic dermatitis at some point in life. In the Eczema Society of Canada's 2025 survey[2], 89% of respondents identified itch reduction as a treatment goal, followed by 86% who wanted reduction in rash and skin symptoms. Finally, according to Psoriasis Canada[3], more than one million Canadians are affected by psoriasis and psoriatic arthritis, chronic inflammatory conditions for which there is currently no known cure for the most common forms of psoriatic disease."I am excited to share with the Delivra Health team the launch of this novel and innovative natural anti-itch cream designed to help individuals manage common dermatological conditions and improve quality of life," said Dr. Joseph Gabriele, the inventor of LivRelief™. "This launch of LivRelief™ Itch Relief Cream aligns with the brand's QUIETS CHRONIC PAIN™ positioning and expands the LivRelief™ portfolio to address the needs of consumers experiencing itchy and irritated skin. LivRelief™ Itch Relief Cream represents an important addition to our innovation pipeline, and we are encouraged by the opportunity to further strengthen the brand through tar...

View stock analysis, news, and events for Delivra Health Brands Inc